-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Claritev, Raises Price Target to $37

Benzinga·07/21/2026 11:20:33
語音播報
Canaccord Genuity analyst Richard Close maintains Claritev (NYSE:CTEV) with a Buy and raises the price target from $32 to $37.